EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Candidozyma ( Candida ) auris– Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation

Laura A Doorley iD, Vanessa Meza-Perez iD, Sarah J Jones iD, Jeffrey M Rybak iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Laura A Doorley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Glucosyltransferases, Plasmids, Gene Editing, Fungal Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, St Jude Children's Research Hospital Children's Infection Defense Center, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mutations in the Candidozyma (Candida) auris β-glucan synthase gene (FKS1) altering S639 are frequently associated with clinical echinocandin resistance. We have developed a novel C auris–optimized episomal plasmid–induced Cas9 (EPIC) gene-editing system capable of recyclable precision editing and demonstrate the contribution of FKS1S639F mutation to echinocandin resistance.

Methods

The EPIC gene-editing system was generated for optimized use in C auris, and ADE2 modification was evaluated in 5 C auris clades. Mutations leading to Fks1S639F and Fks1WT were placed into echinocandin-susceptible and echinocandin-resistant isolates from clades III and I, respectively. Echinocandin susceptibility was determined by Clinical and Laboratory Standards Institute methods. Cell wall abundance of chitin and β-glucan was assessed by staining with calcofluor white and aniline blue.

Results

The EPIC system was capable of targeted ADE2 editing in all tested C auris isolates and precise editing confirmed by sequencing. A single-nucleotide polymorphism (SNP) in FKS1 resulting in either the S639F substitution or a synonymous mutation was introduced in an echinocandin-susceptible clade III isolate. Precision FKS1 editing by the EPIC system was confirmed by whole genome sequencing. Introduction of the Fks1S639F allele increased echinocandin resistance, while correction of the Fks1S639F to the Fks1WT sequence in an echinocandin-resistant clade I isolate restored echinocandin sensitivity. Evaluation of cell wall composition showed strains harboring Fks1S639F to contain significantly elevated β-glucan and chitin content.

Conclusions

These data demonstrate the potential of our EPIC system in its ability to introduce SNPs in multiple C auris clade backgrounds while revealing the direct impact of the S639F-encoding FKS1 mutation on echinocandin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosyltransferasesPlasmidsGene EditingFungal ProteinsCandida aurisDrug Resistance, FungalAntifungal AgentsEchinocandinsMutationMicrobial Sensitivity TestsCRISPR-Cas SystemsHumansbeta-Glucans

Stichwörter der Autor:innen

Candida aurisFKS1CRISPRgene editingresistance

Substanzen

GlucosyltransferasesAntifungal AgentsEchinocandinsFungal Proteinsbeta-Glucansglucan synthase

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee, USA.

ORCID-Profile: Laura A Doorley, Vanessa Meza-Perez, Sarah J Jones, Jeffrey M Rybak

Förderung

  • NIAID NIH HHS
  • St Jude Children's Research Hospital Children's Infection Defense Center
  • NCI NIH HHS
  • St Jude Center for Advanced Genome Engineering
  • Hartwell Center for Bioinformatics and Biotechnology
  • American Lebanese Syrian Associated Charities
  • Society of Infectious Diseases Pharmacists Young Investigator Research
  • National Cancer Institute at the National Institutes of Health

Zitieren

APA

Doorley, L. A., Meza-Perez, V., Jones, S. J., & Rybak, J. M. (2025). A Candidozyma ( Candida ) auris– Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf285

Vancouver

Doorley LA, Meza-Perez V, Jones SJ, Rybak JM. A Candidozyma ( Candida ) auris– Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf285

BibTeX
@article{Doorley2025,
  author = {Doorley, Laura A and Meza-Perez, Vanessa and Jones, Sarah J and Rybak, Jeffrey M},
  title = {A Candidozyma ( Candida ) auris– Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf285}
}
Kostenlos starten →